Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (11): 102-107.doi: 10.6040/j.issn.1671-7554.0.2022.0322

Previous Articles     Next Articles

Prostate clear cell adenocarcinomas: a report of 3 cases and literature review

ZHU Yongcun1, ZHAO Xiushi2, SUN Nannan3, YAO Zhigang4, ZHOU Xingchen5, MU Kun3,6   

  1. 1. Department of Pathology, Weihai Municipal Hospital, Weihai 264200, Shandong, China;
    2. Department of Pathology, Chinese Medicine Hospital of Gaomi, Gaomi 261500, Shandong, China;
    3. Department of Pathology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    4. Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China;
    5. Department of Pathology, The Second Hospital of Shandong University, Jinan 250033, Shandong, China;
    6. Department of Pathology, School of Basic Medical Sciences, Shandong University, Jinan 250012, Shandong, China
  • Online:2022-11-10 Published:2022-11-04

PDF (PC)

64

Abstract: Objective To explore the clinicopathological features and differential diagnosis of primary clear cell adenocarcinoma(CCA)of the prostate. Methods The pathological data of 3 cases of primary prostate CCA were retrospectively analyzed and relevant literature was reviewed. Immunohistochemistry(IHC)was performed with a group of differential antibodies. Results The patients aged 29 to 54 years. The CCA was located in prostatic utricle in 2 cases and in prostatic parenchyma in 1 case. The clinical manifestation was hematospermia in 2 cases and progressive dysuria in 1 case. Microscopically, a mixture of three histological structures were observed, including glandular, papillary and solid patterns. The so-called hobnail pattern was visible in the glandular and papillary surfaces. Immunohistochemically, CK7, PAX-8, HNF-1β were positive, and AMACR, NapsinA, CA125 were partially positive. During the follow-up of 12 to 15 months, 1 patient was lost, 1 developed metastases of the lung and inguinal lymph nodes, and the other had no recurrence or metastasis. Conclusion The serum CA125 level might be elevated while prostate specific antigen(PSA)level is normal for patients with prostate CCA. Young patients with hemospermia should be altered. The diagnosis relies on histopathological examination and immunohistochemical staining. The prognosis of patients with tumor located in prostatic parenchyma is worse than that located in prostatic utricle.

Key words: Prostate, Clear cell adenocarcinoma, Diagnosis, Prognosis

CLC Number: 

  • R365
[1] Grosser D, Matoso A, Epstein JI. Clear cell adenocarcinoma in men: a series of 15 cases [J]. Am J Surg Pathol, 2021, 45(2): 270-276.
[2] Manning J. Case report: transitional cell carcinoma in situ within a urethral diverticulum [J]. Int Urogynecol J, 2012, 23(12): 1801-1803.
[3] Flynn C, Oxley J, McCullagh P, et al. Primary high-grade serous carcinoma arising in the urethra or urethral diverticulum: a report of 2 cases of an extremely rare phenomenon [J]. Int J Gynecol Pathol, 2013, 32(1): 141-145.
[4] Spencer JR, Brodin AG, Ignatoff JM. Clear cell adenocarcinoma of the urethra: evidence for origin within paraurethral ducts[J]. J Urol, 1990, 143(1): 122-125.
[5] Gandhi JS, Khurana A, Tewari A, et al. Clear cell adenocarcinoma of the male urethral tract [J]. Indian J Pathol Microbiol, 2012, 55(2): 245-247.
[6] Klaassen Z, Cleveland C, McCraw CO, et al. Clear cell adenocarcinoma of the prostate: a rare oncologic entity in a 42-year-old African American man [J]. Urology, 2014, 84(5): 997-1000.
[7] Sugimura R, Kawahara T, Noguchi G, et al. Clear cell adenocarcinoma of the prostatic urethra: a case report[J]. IJU Case Rep, 2018, 2(1): 19-22.
[8] Gualco G, Ortega V, Ardao G, et al. Clear cell adenocarcinoma of the prostatic utricle in an adolescent [J]. Ann Diagn Pathol, 2005, 9(3): 153-156.
[9] Chang CW, Yin HL, Li CC. Primary clear cell adenocarcinoma of prostate: a diagnostic challenge [J]. Urol Ann, 2021, 13(4): 434-437.
[10] 刘雯, 袁静萍, 詹娜, 等. 原发性前列腺透明细胞腺癌一例[J]. 中华病理学杂志, 2021, 50(9): 1075-1077. LIU Wen, YUAN Jingping, ZHAN Na, et al. Clear cell adenocarcinoma in the prostate: report of a case [J]. Chinese Journal of Pathology, 2021, 50(9): 1075-1077.
[11] Pan CC, Chiang H, Chang YH, et al. Tubulocystic clear cell adenocarcinoma arising within the prostate [J]. Am J Surg Pathol, 2000, 24(10): 1433-1436.
[12] Oliva E, Amin MB, Jimenez R, et al. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems [J]. Am J Surg Pathol, 2002, 26(2): 190-197.
[13] Miller EM, Sun Y, Richardson I, et al. Vesical clear cell adenocarcinoma arising from endometriosis: a mullerian tumor, indistinguishable from ovarian clear cell adenocarcinoma [J]. Gynecol Oncol Rep, 2016, 18: 8-10. doi: 10.1016/j.gore.2016.08.005.
[14] Loizzi V, Cormio G, Leone L, et al. A rare case of primary clear-cell adenocarcinoma of the bladder arising from bladder endometriosis [J]. J Obstet Gynaecol, 2015, 35(7): 758-760.
[15] Kramer MW, Abbas M, Pertschy S, et al. Clear-cell variant urothelial carcinoma of the bladder: a case report and review of the literature [J]. Rare Tumors, 2012, 4(4): e48.
[16] Venyo AK. Clear cell adenocarcinoma of the urethra: review of the literature [J]. Int J Surg Oncol, 2015, 2015: 790235. doi: 10.1155/2015/790235.
[17] Sung MT, Zhang S, MacLennan GT, et al. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin [J]. Clin Cancer Res, 2008, 14(7): 1947-1955.
[18] Herawi M, Drew PA, Pan CC, et al. Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma [J]. Hum Pathol, 2010, 41(4): 594-601.
[19] Patne SC, Johri N, Katiyar R, et al. Renal-type clear cell carcinoma of the prostate: a diagnostic challenge [J]. Diagn Pathol, 2015, 10: 193. doi: 10.1186/s13000-015-0432-8.
[20] Han SI, Lim SC. Rare case of renal-type clear cell carcinoma of the prostate and review of the literature [J]. In Vivo, 2020, 34(5): 2751-2756.
[21] Liao G, Zhang X, Li Z, et al. Renal-type clear cell carcinoma of prostate: a case report and review of literature [J]. Indian J Pathol Microbiol, 2018, 61(3): 431-433.
[22] Warrick JI, Humphrey PA. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression [J]. Am J Surg Pathol, 2013, 37(11): 1709-1714.
[23] Han B, Mehra R, Suleman K, et al. Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma [J]. Mod Pathol, 2009, 22(9): 1176-1185.
[24] Friedman GT, Carvalhal EF, Martins JA, et al. Nephrogenic adenoma of the prostate after laser therapy of benign prostatic hyperplasia [J]. Urol Case Rep, 2020, 33: 101382. doi: 10.1016/j.eucr.2020.101382.
[25] Kumar L, Narwal A, Kumar M, et al. Primary clear-cell urothelial carcinoma of urinary bladder: a not-so-clear entity with review of literature [J]. BMJ Case Rep, 2019, 12(10): e231192.
[26] Mai KT, Bateman J, Djordjevic B, et al. Clear cell urothelial carcinoma [J]. Int J Surg Pathol, 2017, 25(1): 18-25.
[27] 温宗华, 张小红, 韦海明. 男性苗勒型透明细胞癌一例[J]. 中华病理学杂志, 2018, 47(1): 63-65.
[1] LI Bo-Bo, LI Dao-Tang, LIU Shu-Guang, WANG Xing-Wu. Expression of serum DKK-1 in esophageal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 58-61.
[2] WANG Xin, XING Chun-Yan, YANG Yan-Ping. Serum phosphopyruvate hydratase in diagnosis of invasive Candida albicans infection [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 92-94.
[3] LV Yan-Feng, DING Ke, WANG Jian-Xin, YU Hua-Long, BEI Shao-Sheng. Canceration of chronic anal fistula [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 55-57.
[4] ZHANG Shi-Bao, LIU Qing-Yong, RUAN Xi-Yun, CHEN Jie, ZHANG Jian-Jun, LI Zong-Wu, YANG Guang-Xiao, WANG Quan-Ying. onstruction and identification of the expression vector of
NT4-SAC-HA2-TAT fusion gene [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 15-19.
[5] XU Ping, YU Guo-Fang, LI Xia. Differential diagnosis of Graves′ disease and Hashimoto′s thyroiditis by different types peak systolic velocity of the superior thyroid artery [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 62-64.
[6] ZHENG Su, CHEN Shuhua, LI Hua, DENG Jie, CHEN Chunhong, WANG Xiaohui, FENG Weixing, HAN Xiaodi, ZHANG Yujia, LI Na, LI Mo, FANG Fang. Correlation between EEG variations and BASED evaluation of the efficacy of ACTH treatment in 54 cases of infantile spasms [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 91-96.
[7] WANG Lihui, GAO Min, KONG Beihua. Angiosarcoma of the uterus: a report of 2 cases and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 108-112.
[8] JIANG Ziqing, ZENG Yanping, JI Xiaodong, ZUO Junling. A case report of hemophagocytic syndrome secondary to talaromyces marneffei infection [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 91-97.
[9] HE Shiqing, LI Wanwan, DONG Shuqing, MOU Jingyi, LIU Yuying, WEI Siyu, LIU Zhao, ZHANG Jiaxin. Construction of a prognostic risk model of pyroptosis-related genes in breast cancer based on database [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 34-43.
[10] ZHANG Yufeng, XU Min, XING Xiuli, PANG Shuguang, HU Keqing. Epidemiological characteristics of 689 patients with non-ST-segment elevation myocardial infarction [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 118-122.
[11] XU Zhen, DIAO Tongxiang, ZANG Zhenjie, SHAO Dingchang, ZHANG Qi, SUN Dingqi, FU Qiang. Value of isoform［-2］proprostate-specific antigen and its derivatives in the diagnosis of prostate cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 51-56.
[12] SUN Haoyu, JIANG Xin, CHEN Shouzhen, QU Sifeng, SHI Benkang. Multiparametric magnetic resonance imaging combined with prostate health index in the diagnosis of prostate cancer in 142 patients within PSA grey zone [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 46-50.
[13] ZHANG Jingliang, LIU Xinyu, YUAN Suomao, WANG Lianlei. Causes of misdiagnosis and mistreatment of lumbar degenerative diseases complicated with hip joint diseases(hip-spine syndrome) [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 67-73.
[14] SONG Min, ZHOU Yuxia, GAO Lu, LIU Na, WANG Ju, GU Jin, ZHANG Yanping. Prenatal diagnosis for a fetus of mosaic trisomy 6q [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 109-113.
[15] LI Linlin, WANG Kai. Prediction of hepatocellular carcinoma prognostic genes based on bioinformatics [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 50-58.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] SUO Dongyang, SHEN Fei, GUO Hao, LIU Lichang, YANG Huimin, YANG Xiangdong. Expression and mechanism of Tim-3 in animal model of drug-induced acute kidney injury[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 1 -6 .
[2] ZHANG Baowen, LEI Xiangli, LI Jinna, LUO Xiangjun, ZOU Rong. miR-21-5p targeted TIMP3 to inhibit proliferation and extracellular matrix accumulation of mesangial cells in Type II diabetic nephropathy mice[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 7 -14 .
[3] LONG Tingting, XIE Ming, ZHOU Lu, ZHU Junde. Effect of Noggin protein on learning and memory abilities and the dentate gyrus structure after cerebral ischemia reperfusion injury in mice[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 15 -23 .
[4] FU Jieqi, ZHANG Man, ZHANG Xiaolu, LI Hui, CHEN Hong. Molecular mechanism of Toll-like receptor 4 in the aggravation of blood lipid accumulation by inhibiting the peroxisome proliferator-activate receptor γ[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 24 -31 .
[5] MA Qingyuan, PU Peidong, HAN Fei, WANG Chao, ZHU Zhoujun, WANG Weishan, SHI Chenhui. Effect of miR-27b-3p regulating SMAD1 on osteosarcoma cell proliferation, migration and invasion[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 32 -37 .
[6] LI Ning, LI Juan, XIE Yan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 38 -46 .
[7] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 47 -52 .
[8] XIAO Juan, XIAO Qiang, CONG Wei, LI Ting, DING Shouluan, ZHANG Yuan, SHAO Chunchun, WU Mei, LIU Jianing, JIA Hongying. Comparison of diagnostic efficacy of two kinds of thyroid imagine reporting and data systems[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 53 -59 .
[9] DING Xiangyun, YU Qingmei, ZHANG Wenfang, ZHUANG Yuan, HAO Jing. Correlation of the expression of insulin-like growth factor II in granulosa cells and ovulation induction outcomes of 84 patients with polycystic ovary syndrome[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 60 -66 .
[10] XU Yuxiang, LIU Yudong, ZHANG Peng, DUAN Ruisheng. A retrospective analysis of risk factors of cerebral microbleeds in 101 patients with cerebral small vessel disease[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 67 -71 .
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd